White Sox reliever Jordan Leasure undergoes UCL surgery, to miss all of 2027

White Sox reliever Jordan Leasure underwent surgery to repair a UCL tear, the club announced, with the procedure having taken place a few weeks ago per MLB.com's Scott Merkin. Per the announcement, Leasure is expected to miss the entire 2027 season and return in time for Spring Training 2028 — making this, in practical terms, a two-year absence from a bullpen that had come to rely on him.

What happened

The club announced that Leasure, 28, was shut down in late May after attempting to pitch through elbow discomfort. At that point, the team's initial diagnosis was a flexor strain. The announcement clarifies that the injury also involved ligament damage, which ultimately required the reconstructive operation. Leasure made 18 appearances this season before being shut down.

The gap between "flexor strain" and "UCL tear requiring reconstruction" is a familiar and uncomfortable one for baseball fans. The elbow has a way of presenting its full invoice only after the first estimate has already been filed.

Why it matters

Leasure was not a depth piece. He had worked his way into leverage situations for Chicago and, per the club's announcement relayed by Merkin, led White Sox relievers with 80 strikeouts in 2025 while picking up seven saves across 64 1/3 innings. That is the kind of reliever profile — high-strikeout, trusted in close games — that organizations spend years developing and considerable effort replacing.

The timing compounds the operational weight. The White Sox are 74-68 and sitting atop the AL Central with a division magic number of 18. This is not a franchise in quiet rebuild mode absorbing a roster loss with a shrug. Chicago is in a pennant race, and the bullpen is being asked to protect leads that matter in the standings right now. Leasure's absence is not a 2026 problem in the immediate sense — he was already shut down — but the knowledge that he will not be available in 2027 either reshapes how the organization thinks about its relief corps heading into the offseason.

The numbers

Leasure's 2025 season line tells the story of a reliever who had genuinely arrived. He posted a 3.92 ERA across 64 1/3 innings, led White Sox relievers with 80 strikeouts, and earned seven saves while working in leverage spots. Those are not the numbers of a fungible arm; they are the numbers of a reliever a contending club builds around.

This season, per the announcement, Leasure allowed 14 runs across his 18 appearances before being shut down — a notably steeper rate than his 2025 work, though the elbow discomfort he was pitching through offers context the raw line alone does not.

Where the club stands

The White Sox enter September at 74-68 (.521), leading the AL Central with a division magic number of 18 and carrying a one-game losing streak into a road series at Houston. The rotation lines up Anthony Kay against Peter Lambert on Monday, Sean Burke against Ronel Blanco on Tuesday, and Davis Martin against Hayden Wesneski on Wednesday at Daikin Park.

That Houston series arrives at an interesting moment. Two days ago, the White Sox were riding a four-game winning streak that had pushed them to 8 games over .500 — a remarkable position for a club that opened 2026 at 6-13 and 7-14. The streak ended, but the division lead did not. Chicago has also been active at the roster margins this week, with the club acquiring outfielder Tommy Pham from the Phillies and adding Jake Cave from the Rays for cash, the latter on a minor-league deal and reportedly eligible for postseason consideration. The front office, in other words, is not treating this as a year to watch from a comfortable distance.

The September roster expansion — rosters can grow to 28 players from September 1 through the end of the regular season under current league rules — gives the White Sox some flexibility to carry additional arms as the pennant race tightens. That flexibility does not conjure a Leasure replacement, but it does allow the club to carry depth it could not afford in August.

What we don't know yet

The announcement does not specify the exact date of the surgery beyond "a few weeks ago," per Merkin's relay. The club has not detailed which relievers are expected to absorb Leasure's leverage role for the remainder of 2026, nor has any offseason plan for replacing his production been reported. The announcement addresses the 2027 absence and the Spring Training 2028 target; everything between now and then remains unaddressed publicly.

It is also worth noting that the initial diagnosis — a flexor strain — did not capture the full picture. The announcement acknowledges that ligament damage was also present. Whether that sequence affects how the club approaches future elbow-related diagnoses is not something the announcement addresses, and the desk is not in the business of drawing that line for them.

What to watch

### Will Leasure's role be filled internally or externally this offseason?

Per the announcement, Leasure is not expected to be available until Spring Training 2028, which means the White Sox will enter the 2027 season without the reliever who led their bullpen in strikeouts in 2025. Whether the club addresses that gap through free agency, a trade, or internal development has not been reported. Given that Chicago is currently leading the AL Central and has already demonstrated a willingness to add pieces at the deadline — the Pham and Cave acquisitions arrived just two days ago — the offseason bullpen question will be worth tracking closely once the 2026 season concludes.

For now, the more immediate watch is how the White Sox bullpen manages the final weeks of a pennant race without a reliever who, when healthy, was their most productive strikeout arm. The magic number is 18. The road trip to Houston starts Monday. The elbow, unfortunately, is not on the active roster.